Literature DB >> 4042691

Assignment of uroporphyrinogen decarboxylase (UROD) to the pter----p21 region of human chromosome 1.

T McLellan, M A Pryor, J P Kushner, R L Eddy, T B Shows.   

Abstract

The assignment of the human gene for uroporphyrinogen decarboxylase (UROD) to chromosome 1 is confirmed and further localized to the pter----p21 region through the use of human-mouse somatic cell hybrids. Human and mouse UROD were separated by electrophoresis and identified with antibodies to the human enzyme after electrophoretic transfer to nitrocellulose membranes.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4042691     DOI： 10.1159/000132139

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN： 0301-0171


  5 in total

1.  Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.

Authors:  J L Hansen; M A Pryor; J B Kennedy; J P Kushner
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

2.  Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping.

Authors:  C Wu; W Xu; C A Kozak; R J Desnick
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

3.  Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1.

Authors:  A Dubart; M G Mattei; N Raich; D Beaupain; P H Romeo; J F Mattei; M Goossens
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

4.  Substrate shuttling between active sites of uroporphyrinogen decarboxylase is not required to generate coproporphyrinogen.

Authors:  John D Phillips; Christy A Warby; Frank G Whitby; James P Kushner; Christopher P Hill
Journal:  J Mol Biol       Date:  2009-04-10       Impact factor: 5.469

5.  Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study.

Authors:  Yung-An Tsou; Kuan-Chung Chen; Hung-Che Lin; Su-Sen Chang; Calvin Yu-Chian Chen
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.